Taking together the increased exenatide blood levels and the increased endogenous GLP-1 levels, these data serve as a strong proof of concept regarding the effectiveness of our nanosystem in ameliorating T2DM symptoms. This evidence concerns the gene GCG and type 2 diabetes mellitus.